Sirona Biochem Company Top Insiders
| SRBCF Stock | USD 0.05 0 9.89% |
Sirona Biochem employs about 12 people. The company is managed by 4 executives with a total tenure of roughly 28 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive. Examination of Sirona Biochem's management performance can provide insight into the company performance.
| CPA CGA Insider CFO Director |
| Graldine DeliencourtGodefroy Insider Chief Director |
Sirona |
Sirona Biochem Management Team Effectiveness
The company has return on total asset (ROA) of (1.3502) % which means that it has lost $1.3502 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (35.557) %, meaning that it generated substantial loss on money invested by shareholders. Sirona Biochem's management efficiency ratios could be used to measure how well Sirona Biochem manages its routine affairs as well as how well it operates its assets and liabilities.Sirona Biochem Workforce Comparison
Sirona Biochem Corp is currently regarded as top stock in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 107. Sirona Biochem retains roughly 12.0 in number of employees claiming about 11% of equities under Health Care industry.
Sirona Biochem Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Sirona Biochem Corp Price Series Summation is a cross summation of Sirona Biochem price series and its benchmark/peer.
Sirona Biochem Notable Stakeholders
A Sirona Biochem stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sirona Biochem often face trade-offs trying to please all of them. Sirona Biochem's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sirona Biochem's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| CPA CGA | CFO Director | Profile | |
| Graldine DeliencourtGodefroy | Chief Director | Profile | |
| Michelle MBA | VP Operations | Profile | |
| Brett Premack | Scientific Consultant | Profile |
About Sirona Biochem Management Performance
The success or failure of an entity such as Sirona Biochem Corp often depends on how effective the management is. Sirona Biochem management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sirona management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sirona management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Sirona Biochem is traded on OTC Exchange in the United States.
Sirona Biochem Workforce Analysis
Traditionally, organizations such as Sirona Biochem use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sirona Biochem within its industry.Sirona Biochem Manpower Efficiency
Return on Sirona Biochem Manpower
| Revenue Per Employee | 22.3K | |
| Revenue Per Executive | 67K | |
| Net Loss Per Employee | 192.2K | |
| Net Loss Per Executive | 576.6K | |
| Working Capital Per Employee | 57.7K | |
| Working Capital Per Executive | 173K |
Complementary Tools for Sirona Pink Sheet analysis
When running Sirona Biochem's price analysis, check to measure Sirona Biochem's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sirona Biochem is operating at the current time. Most of Sirona Biochem's value examination focuses on studying past and present price action to predict the probability of Sirona Biochem's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sirona Biochem's price. Additionally, you may evaluate how the addition of Sirona Biochem to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |